Armando Santoro

Researcher Next ID · RN-002651

Researcher · Medicine

Rozzano, Italy

Not currently recruitingFunding unknown

Research interests

Medicine

Lymphoma Diagnosis and Treatment

Lung Cancer Treatments and Mutations

CAR-T cell therapy research

Chronic Lymphocytic Leukemia Research

Cancer Immunotherapy and Biomarkers

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
JAMA Oncology · 2020 · https://doi.org/10.1001/jamaoncol.2020.4564
Ceritinib in ALK -Rearranged Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1311107
Sorafenib in Advanced Hepatocellular Carcinoma
New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmoa0708857
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
New England Journal of Medicine · 2004 · https://doi.org/10.1056/nejmoa033025
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
Annals of Oncology · 2004 · https://doi.org/10.1093/annonc/mdh097

No projects listed.